Product NDC: | 0228-2539 |
Proprietary Name: | Carbidopa and levodopa |
Non Proprietary Name: | Carbidopa and levodopa |
Active Ingredient(s): | 25; 100 mg/1; mg/1 & nbsp; Carbidopa and levodopa |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0228-2539 |
Labeler Name: | Actavis Elizabeth LLC |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA074260 |
Marketing Category: | ANDA |
Start Marketing Date: | 19930901 |
Package NDC: | 0228-2539-96 |
Package Description: | 1000 TABLET in 1 BOTTLE (0228-2539-96) |
NDC Code | 0228-2539-96 |
Proprietary Name | Carbidopa and levodopa |
Package Description | 1000 TABLET in 1 BOTTLE (0228-2539-96) |
Product NDC | 0228-2539 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Carbidopa and levodopa |
Dosage Form Name | TABLET |
Route Name | ORAL |
Start Marketing Date | 19930901 |
Marketing Category Name | ANDA |
Labeler Name | Actavis Elizabeth LLC |
Substance Name | CARBIDOPA; LEVODOPA |
Strength Number | 25; 100 |
Strength Unit | mg/1; mg/1 |
Pharmaceutical Classes | Aromatic Amino Acid Decarboxylation Inhibitor [EPC],DOPA Decarboxylase Inhibitors [MoA],Aromatic Amino Acid Decarboxylation Inhibitor [EPC],DOPA Decarboxylase Inhibitors [MoA] |